09:23 AM EST, 02/11/2025 (MT Newswires) -- Health care stocks were mixed premarket Tuesday as the Health Care Select Sector SPDR Fund ( XLV ) was down a slight 0.2% and the iShares Biotechnology ETF (IBB) was recently inactive.

Humana (HUM) shares rose nearly 3% after the company reported an increase in Q4 revenue and issued a 2025 revenue outlook above analysts' expectations.

Biohaven ( BHVN ) shares advanced by over 7% after the company said the Food and Drug Administration accepted for priority review its new drug application for troriluzole to treat adult patients with spinocerebellar ataxia.

Royalty Pharma ( RPRX ) shares were down more than 0.4% after the company reported lower Q4 net income and revenue.